Title:
ＲＩＰＫ２阻害剤およびそれを用いた癌の治療方法
Document Type and Number:
Japanese Patent JP6545262
Kind Code:
B2
Abstract:
The invention is a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).
Inventors:
Lauffer, Radslow
En, Grace
Brox, richard
Pauls, Hines W.
Lee, Say-One
Mason, Jacqueline M.
Bray, Mark Earl.
En, Grace
Brox, richard
Pauls, Hines W.
Lee, Say-One
Mason, Jacqueline M.
Bray, Mark Earl.
Application Number:
JP2017522496A
Publication Date:
July 17, 2019
Filing Date:
October 09, 2015
Export Citation:
Assignee:
UNIVERSITY HEALTH NETWORK
International Classes:
C07D487/04; A61K31/519; A61K31/5377; A61P29/00; A61P35/00; A61P37/02; A61P43/00
Domestic Patent References:
| JP2011503115A | ||||
| JP2014504622A | ||||
| JP2014515730A | ||||
| JP2013526484A |
Attorney, Agent or Firm:
Yoshinori Hosoda